Recently, it was demonstrated that the level of expression of hepatic interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) mRNA predicts the IFNα therapeutic response in patients with hepatocellular carcinoma [15]. This evidence concerns the gene IFIT3 and hepatocellular carcinoma.